Absence of favourable changes in circulating levels of interleukin-16 or β-chemokine concentration following structured intermittent interruption treatment.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Effect of highly active anti-retroviral therapy and hepatitis C virus co-infection on serum levels of pro-inflammatory and immunoregulatory cytokines.
Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following.
Chlamydophila pneumoniae
Gut bacterial microbiota and obesity
S. S. Pullamsetti, R. Savai, W. Janssen, B. K. Dahal, W. Seeger, F
Approach to diagnosis of infective endocarditis
R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz 
Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral co-infection  E. Cordero, P. Pérez-Romero,
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Virological tools to diagnose and monitor hepatitis C virus infection
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
A. Domínguez-Gil Hurlé, A. Sánchez Navarro, M.J. García Sánchez 
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Clinical Microbiology and Infection
Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide  F.G. Araujo, T.L. Slifer, J.S. Remington  Clinical.
Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain  J.-M. Aguado, C. Lumbreras, D.
Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage.
Vector control: a cornerstone in the malaria elimination campaign
The role of vaccination in preventing pneumococcal disease in adults
Modifications of haematological series in patients co-infected with human immunodeficiency virus and hepatitis C virus during treatment with interferon.
Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients 
Oral versus intravenous therapy in the treatment of systemic mycosis
Training for the infectious diseases speciality in Norway
Epidemiology of Pneumocystis carinii pneumonia in southern Spain
Retrospective study of CMV retinitis in patients with AIDS
Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated.
CMI editorial report 2011 Clinical Microbiology and Infection
C. Fabrizio, A. Procopio  Clinical Microbiology and Infection 
Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response.
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Elements of design: the knowledge on which we build
A rapid chemokine response of macrophage inflammatory protein (MIP)-1α, MIP-1β and the regulated on activation, normal T expressed and secreted chemokine.
Levofloxacin in the treatment of ventilator-associated pneumonia
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Metagenomics and probiotics
Hepatitis B and C virus-related carcinogenesis
W.A. Craig  Clinical Microbiology and Infection 
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
T.M. File  Clinical Microbiology and Infection 
Evidence for human immunodeficiency virus and Cryptococcus neoformans interactions in the pro-inflammatory and anti-inflammatory responses in blood during.
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Factors related to the chronicity and evolution of hepatitis C infection in patients co- infected by the human immunodeficiency virus  R. Pérez-Cano, C.
Current experience in treating invasive zygomycosis with posaconazole
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
Overview of cefixime use in community-acquired infections
Tuberculosis in HIV-infected patients: a comprehensive review
Control of human cytomegalovirus infection in patients infected with human immunodeficiency virus by high levels of specific CD8+ T-cells  D. Lilleri,
Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus  J.A.
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Serum ferritin levels in West Nile encephalitis
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Absence of favourable changes in circulating levels of interleukin-16 or β-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection  M. Montes de Oca Arjona, R. Pérez Cano, M.J. Orozco, A. Martín Aspas, F. Guerrero, C. Fernández Gutiérrez del Álamo, J.A. Girón- González  Clinical Microbiology and Infection  Volume 11, Issue 1, Pages 57-62 (January 2005) DOI: 10.1111/j.1469-0691.2004.01033.x Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Serum concentrations of interleukin (IL)-16, monocyte inhibitory protein-1β (MIP-1β), RANTES (‘regulated upon activation, normal T-cell expressed and presumably secreted') and monocyte chemotactic protein-1 (MCP-1) in patients with chronic human immunodeficiency virus infection, after three cycles of structured intermittent interruption of highly active anti-retroviral treatment (8 weeks on/4 weeks off). Clinical Microbiology and Infection 2005 11, 57-62DOI: (10.1111/j.1469-0691.2004.01033.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com Inc. All rights reserved.